1. AGHAJANIAN, G. K., & FREEDMAN, D. X. Biochemical and morphological aspects of LSD pharmacology. In D. H. Efron (Ed.), Psychopharmacology A Review of Progress 1957–1967. Washington, D. C.: Public Health Service Publication No. 1836, 1968.
2. AMIN, A. H., CRAWFORD, T. B. B., & GADDUM, H. J. The distribution of substance P and 5-hydroxytryptamine in the central nervous system of the dog. Journal of Physiology, 1954, 126, 596–618.
3. AXELROD, J. Enzymatic formation of psychotomimetic metabolites from normally occurring compounds. Science, 1961, 134, 343.
4. BAN, T. A. Ongoing national collaborative studies in Canada: Niacin in the treatment of schizophrenia. Psychopharmacology Bulletin, 1969, 5, 5–20.
5. BELL, C. E., & SOMERVILLE, A. R. Identity of the “pink spot”. Nature, 1966, 211, 1405–1406.